Your browser doesn't support javascript.
loading
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival.
Guilhamon, Paul; Chesnelong, Charles; Kushida, Michelle M; Nikolic, Ana; Singhal, Divya; MacLeod, Graham; Madani Tonekaboni, Seyed Ali; Cavalli, Florence Mg; Arlidge, Christopher; Rajakulendran, Nishani; Rastegar, Naghmeh; Hao, Xiaoguang; Hassam, Rozina; Smith, Laura J; Whetstone, Heather; Coutinho, Fiona J; Nadorp, Bettina; Ellestad, Katrina I; Luchman, H Artee; Chan, Jennifer Ai-Wen; Shoichet, Molly S; Taylor, Michael D; Haibe-Kains, Benjamin; Weiss, Samuel; Angers, Stephane; Gallo, Marco; Dirks, Peter B; Lupien, Mathieu.
Affiliation
  • Guilhamon P; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Chesnelong C; Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain tumor Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Kushida MM; Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain tumor Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Nikolic A; Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain tumor Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Singhal D; Clark Smith Brain Tumour Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.
  • MacLeod G; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada.
  • Madani Tonekaboni SA; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Cavalli FM; Clark Smith Brain Tumour Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.
  • Arlidge C; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada.
  • Rajakulendran N; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Rastegar N; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
  • Hao X; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Hassam R; Department of Medical Biophysics, University of Toronto, Toronto, Canada.
  • Smith LJ; Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain tumor Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Whetstone H; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Coutinho FJ; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
  • Nadorp B; Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain tumor Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Ellestad KI; Clark Smith Brain Tumour Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.
  • Luchman HA; Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
  • Chan JA; Department of Cell Biology & Anatomy, University of Calgary, Calgary, Canada.
  • Shoichet MS; Clark Smith Brain Tumour Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.
  • Taylor MD; Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
  • Haibe-Kains B; Department of Cell Biology & Anatomy, University of Calgary, Calgary, Canada.
  • Weiss S; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
  • Angers S; Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain tumor Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Gallo M; Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain tumor Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Dirks PB; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Lupien M; Clark Smith Brain Tumour Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.
Elife ; 102021 01 11.
Article in En | MEDLINE | ID: mdl-33427645
ABSTRACT
Chromatin accessibility discriminates stem from mature cell populations, enabling the identification of primitive stem-like cells in primary tumors, such as glioblastoma (GBM) where self-renewing cells driving cancer progression and recurrence are prime targets for therapeutic intervention. We show, using single-cell chromatin accessibility, that primary human GBMs harbor a heterogeneous self-renewing population whose diversity is captured in patient-derived glioblastoma stem cells (GSCs). In-depth characterization of chromatin accessibility in GSCs identifies three GSC states Reactive, Constructive, and Invasive, each governed by uniquely essential transcription factors and present within GBMs in varying proportions. Orthotopic xenografts reveal that GSC states associate with survival, and identify an invasive GSC signature predictive of low patient survival, in line with the higher invasive properties of Invasive state GSCs compared to Reactive and Constructive GSCs as shown by in vitro and in vivo assays. Our chromatin-driven characterization of GSC states improves prognostic precision and identifies dependencies to guide combination therapies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Chromatin / Glioblastoma / Cell Self Renewal Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Elife Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Chromatin / Glioblastoma / Cell Self Renewal Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Elife Year: 2021 Document type: Article Affiliation country:
...